Ocular hypertension (OHT)
Clinical trials for Ocular hypertension (OHT) explained in plain language.
Never miss a new study
Get alerted when new Ocular hypertension (OHT) trials appear
Sign up with your email to follow new studies for Ocular hypertension (OHT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Glaucoma implant tested for Office-Based eye care
Disease control Recruiting nowResearchers are observing whether a tiny implant that releases travoprost can be safely placed inside the eye during an office visit. The implant is designed to lower eye pressure in people with open angle glaucoma or ocular hypertension. The study follows 30 participants to see …
Matched conditions: OCULAR HYPERTENSION (OHT)
Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New Non-Contact laser could make glaucoma treatment easier
Disease control Recruiting nowThis study compares two FDA-approved laser treatments for open-angle glaucoma: the standard SLT and a newer, non-contact version called DSLT. Both aim to lower eye pressure and prevent vision loss. About 172 adults with glaucoma or high eye pressure will be randomly assigned to o…
Matched conditions: OCULAR HYPERTENSION (OHT)
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New implant could replace glaucoma drops after cataract surgery
Disease control Recruiting nowThis study tests a tiny implant placed inside the eye during cataract surgery that slowly releases travoprost, a drug that lowers eye pressure. About 132 adults with glaucoma or high eye pressure will receive either the implant plus surgery or surgery alone. The goal is to see if…
Matched conditions: OCULAR HYPERTENSION (OHT)
Phase 4 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC